To investigate whether CSNK1D is required for GLI-driven tumor initiation in vivo, we performed xenograft experiments using GLI1-dependent A673 and GLI1-dependent PANC1 pancreatic cancer cells [60] with concomitant inhibition of CSNK1D. This evidence concerns the gene CSNK1D and pancreatic neoplasm.